Cas:37074-17-2 N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine manufacturer & supplier

Chemical Name:N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine

CAS.NO:37074-17-2

Synonyms:Silanamine, N,1,1,1-tetramethyl-N-(trimethylsilyl)-;2,2,5,5-Tetramethyl-3-aza-2,5-disilahexan;N-Trimethylsilyl-trimethylsilylmethylamin;N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine

Molecular Formula:C₇H₂₁NSi₂

Molecular Weight:175.419

HS Code:2942000000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:149.0±23.0 °C at 760 mmHg

Density:0.8±0.1 g/cm3

Index of Refraction:1.414

PSA:3.24000

Exact Mass:175.121246

LogP:2.29

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2924

Packing Group:III

Contact us for information like Silanamine, N,1,1,1-tetramethyl-N-(trimethylsilyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2,5,5-Tetramethyl-3-aza-2,5-disilahexan Use and application,2,2,5,5-Tetramethyl-3-aza-2,5-disilahexan technical grade,usp/ep/jp grade.

Related News: Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine manufacturer Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine supplier Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine vendor In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. N,1,1,1-Tetramethyl-N-(trimethylsilyl)silanamine factory Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase.